These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11427995)

  • 1. Benefits from early treatment of HIV-1 infection.
    Klein D
    Trends Mol Med; 2001 Jan; 7(1):9. PubMed ID: 11427995
    [No Abstract]   [Full Text] [Related]  

  • 2. Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent disease.
    Kubo M; Nishimura Y; Shingai M; Lee W; Brenchley J; Lafont B; Buckler-White A; Igarashi T; Martin MA
    J Virol; 2009 Jul; 83(14):7099-108. PubMed ID: 19420078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
    Marcello A; Giacca M
    Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
    Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
    Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy.
    Kearney MF; Anderson EM; Coomer C; Smith L; Shao W; Johnson N; Kline C; Spindler J; Mellors JW; Coffin JM; Ambrose Z
    Retrovirology; 2015 Nov; 12():93. PubMed ID: 26559632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy.
    Horiike M; Iwami S; Kodama M; Sato A; Watanabe Y; Yasui M; Ishida Y; Kobayashi T; Miura T; Igarashi T
    Virology; 2012 Feb; 423(2):107-18. PubMed ID: 22196013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of SIV rebound through structured treatment interruptions during early infection.
    Lori F; Lewis MG; Xu J; Varga G; Zinn DE; Crabbs C; Wagner W; Greenhouse J; Silvera P; Yalley-Ogunro J; Tinelli C; Lisziewicz J
    Science; 2000 Nov; 290(5496):1591-3. PubMed ID: 11090360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.
    Zhang Z; Schuler T; Zupancic M; Wietgrefe S; Staskus KA; Reimann KA; Reinhart TA; Rogan M; Cavert W; Miller CJ; Veazey RS; Notermans D; Little S; Danner SA; Richman DD; Havlir D; Wong J; Jordan HL; Schacker TW; Racz P; Tenner-Racz K; Letvin NL; Wolinsky S; Haase AT
    Science; 1999 Nov; 286(5443):1353-7. PubMed ID: 10558989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.
    DiNapoli SR; Ortiz AM; Wu F; Matsuda K; Twigg HL; Hirsch VM; Knox K; Brenchley JM
    JCI Insight; 2017 Feb; 2(4):e91214. PubMed ID: 28239657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
    Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
    J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug makes host cell machinery unavailable to HIV.
    Senior K
    Mol Med Today; 1999 Jun; 5(6):234-5. PubMed ID: 10366815
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
    North TW; Van Rompay KK; Higgins J; Matthews TB; Wadford DA; Pedersen NC; Schinazi RF
    J Virol; 2005 Jun; 79(12):7349-54. PubMed ID: 15919889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
    Finzi D; Hermankova M; Pierson T; Carruth LM; Buck C; Chaisson RE; Quinn TC; Chadwick K; Margolick J; Brookmeyer R; Gallant J; Markowitz M; Ho DD; Richman DD; Siliciano RF
    Science; 1997 Nov; 278(5341):1295-300. PubMed ID: 9360927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful simplification of HAART in patients with acute primary HIV infection.
    Sinicco A; Bonora S; Arnaudo I; Zeme DA; Audagnotto S; Raiteri R; Di Perri G
    J Biol Regul Homeost Agents; 2002; 16(1):69-72. PubMed ID: 12003178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS. Boosting immunity to HIV--can the virus help?
    Autran B; Carcelain G
    Science; 2000 Nov; 290(5493):946-9. PubMed ID: 11184735
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of hydroxyurea during structured treatment interruptions.
    Foli A; Seminari E; Ravot E; Lisziewicz J; Lori F
    J Biol Regul Homeost Agents; 2002; 16(1):64-8. PubMed ID: 12003177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HIV therapeutic approaches in animal models].
    Dormont D
    Rev Med Interne; 2002 Dec; 23 Suppl 5():532s-534s. PubMed ID: 12701243
    [No Abstract]   [Full Text] [Related]  

  • 19. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
    Wong JK; Hezareh M; Günthard HF; Havlir DV; Ignacio CC; Spina CA; Richman DD
    Science; 1997 Nov; 278(5341):1291-5. PubMed ID: 9360926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.